4.7 Article

Oxidized High-Density Lipoprotein Shows a Stepwise Increase as Fibrosis Progresses in Patients with Nonalcoholic Fatty Liver Disease

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Lean NAFLD: an underrecognized and challenging disorder in medicine

Sheila Maier et al.

Summary: NAFLD is not only associated with obesity but can also occur in individuals with normal body weight. Research on Lean NAFLD helps to better understand the risk factors, disease progression, and potential treatments for this condition.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2021)

Review Medicine, General & Internal

Noninvasive biomarkers in predicting nonalcoholic steatohepatitis and assessing liver fibrosis: systematic review and meta-analysis

Abdulrahman Ismaiel et al.

Summary: This study found that FIB-4 had better accuracy in predicting NASH and assessing liver fibrosis in NASH patients, particularly in distinguishing fibrosis stages 0 vs. 1-4, compared to other biomarkers.

PANMINERVA MEDICA (2021)

Article Gastroenterology & Hepatology

HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure

Markus Trieb et al.

JOURNAL OF HEPATOLOGY (2020)

Review Cardiac & Cardiovascular Systems

High Density Lipoproteins: Metabolism, Function, and Therapeutic Potential

Anne Jomard et al.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)

Article Cardiac & Cardiovascular Systems

Oxidized HDL, as a Novel Biomarker for Calcific Aortic Valve Disease, Promotes the Calcification of Aortic Valve Interstitial Cells

Jia Teng Sun et al.

JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2019)

Review Gastroenterology & Hepatology

Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers

Eduardo Vilar-Gomez et al.

JOURNAL OF HEPATOLOGY (2018)

Review Cardiac & Cardiovascular Systems

Dysfunctional HDL and atherosclerotic cardiovascular disease

Robert S. Rosenson et al.

NATURE REVIEWS CARDIOLOGY (2016)

Article Gastroenterology & Hepatology

Statin use and non-alcoholic steatohepatitis in at risk individuals

Paola Dongiovanni et al.

JOURNAL OF HEPATOLOGY (2015)

Review Gastroenterology & Hepatology

Non-alcoholic steatohepatitis: The role of oxidized low-density lipoproteins

Sofie M. A. Walenbergh et al.

JOURNAL OF HEPATOLOGY (2013)

Review Gastroenterology & Hepatology

Lipoprotein Metabolism, Dyslipidemia, and Nonalcoholic Fatty Liver Disease

David E. Cohen et al.

SEMINARS IN LIVER DISEASE (2013)

Article Gastroenterology & Hepatology

Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population

Yoshio Sumida et al.

BMC GASTROENTEROLOGY (2012)

Article Medical Laboratory Technology

Oxidized high-density lipoprotein is associated with increased plasma glucose in non-diabetic dyslipidemic subjects

Kazuhiko Kotani et al.

CLINICA CHIMICA ACTA (2012)

Article Gastroenterology & Hepatology

Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Amy G. Shah et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)

Article Gastroenterology & Hepatology

The Plasma Lipidomic Signature of Nonalcoholic Steatohepatitis

Puneet Puri et al.

HEPATOLOGY (2009)

Article Gastroenterology & Hepatology

Long-term follow-up of patients with NAFLD and elevated liver enzymes

Mattias Ekstedt et al.

HEPATOLOGY (2006)

Article Gastroenterology & Hepatology

Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis

N Chalasani et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)

Article Hematology

Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease

P Holvoet et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)